BUSINESS● LOWSep 22 · Sep 22, 2026, 12:02 PM
Viking Therapeutics soars after trial data for obesity drug
Seeking Alpha Tech · global
Viking Therapeutics' stock has risen significantly following the release of positive trial data for its obesity drug. This indicates a favorable market reaction to the company's pharmaceutical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS3m agoIn Kenya, the cancellation of the Vodafone-Safaricom deal threatens to weigh on the country's financesJeune AfriqueBUSINESS28m agoCLPS GAAP EPS of -$0.39, revenue of $87.1MSeeking Alpha Tech